International Journal of Vasculitis

International Journal of Vasculitis

International Journal of Vasculitis – Editorial Policies

Open Access & Peer-Reviewed

Submit Manuscript
Open Access & Peer-Reviewed

International Journal of Vasculitis - Editorial Policies

Clear policies that protect research integrity

Core Editorial Standards

International Journal of Vasculitis follows rigorous editorial policies to ensure fairness, transparency, and research integrity.

Policies guide peer review, ethics compliance, conflicts of interest, data transparency, and corrections.

All manuscripts undergo editorial screening and peer review by subject experts. Decisions are based on methodological quality, originality, and relevance.

Ethical approval is required for human or animal studies, and authors must disclose conflicts of interest.

Plagiarism screening is performed for all submissions. Suspected misconduct is handled in accordance with publishing ethics guidance.

All authors must meet contribution standards and approve the final manuscript.

Submissions must be original and not under review elsewhere.

Corrections and retractions are issued transparently when required.

Conflicts of interest must be disclosed for authors, reviewers, and editors.

Ethics approvals are required for studies using human or animal materials.

Data sharing exceptions must be justified and documented in the manuscript.

Reviewer identities are protected and manuscripts are treated as confidential.

Editorial decisions are based on scientific merit and scope relevance.

We follow COPE guidance for ethical oversight, corrections, and retractions.

Plagiarism screening is performed on all submissions before peer review.

Clinical trials should be registered prior to enrollment and include registry identifiers.

Patient consent is required for identifiable data, images, or case details.

Data integrity concerns may trigger requests for raw data or audit trails.

Appeals are reviewed by senior editors not involved in the original decision.

Preprint posting is permitted but must be disclosed at submission.

Generative AI tools may be used for language support but must be disclosed and cannot be listed as authors.

Duplicate publication is not permitted and will be investigated if suspected.

Image manipulation beyond standard adjustments is not allowed.

Authorship disputes are handled according to COPE recommendations.

Data fabrication or falsification results in rejection and potential notification.

Corrections are linked to the original article to preserve the record.

We reserve the right to request ethics documentation at any stage of review.

Submissions may undergo statistical review when complex analyses are presented.

Funding sources must be disclosed along with the sponsor's role in study design and analysis.

Policy Highlights

1

Merit Based Decisions

Editorial decisions are based on scientific quality and relevance.

2

Ethics Compliance

Human and animal studies must meet ethical standards.

3

Conflict Disclosure

Authors, reviewers, and editors must disclose conflicts.

4

Data Transparency

Data availability statements are required for all submissions.

Policy Areas

Integrity and Transparency

Required

Policies address originality, authorship, data integrity, and data deposition documentation.

  • Original work only
  • Authorship contributions documented
  • Data integrity required
  • Reporting compliance

Ethics and Consent

Compliance

Ethics approvals and informed consent are required where applicable.

  • IRB approvals documented
  • Animal welfare compliance
  • Clinical trial registration
  • Conflicts disclosed

Policy Checklist

Checklist

Keep these core expectations in place at submission.

  • Originality
  • Ethics
  • Data

Policy Table

Policy AreaRequirementAuthor Action
OriginalityNo prior publicationDisclose preprints
EthicsApprovals and complianceInclude identifiers
DataAvailability statementProvide links or access terms

Ethics and Consent

Ethics approvals are required for studies using human or animal materials.

Corrections and Misconduct

Concerns are handled through corrections, expressions of concern, or retractions.

Policy Compliance

Step 1

Ethics and Consent

Provide IRB or ethics committee approvals where required.

Step 2

Conflict Disclosure

Disclose financial or professional conflicts of interest.

Step 3

Data Statements

Include data availability statements and supporting documentation.

Additional Guidance

Confidentiality is required throughout review.

Concerns should be raised early for transparent resolution.

Policies protect the credibility of vasculitis research.

Policy FAQs

Are preprints allowed?

Yes. Disclose preprints at submission and update records after acceptance.

How are misconduct cases handled?

We follow COPE guidance and investigate cases fairly.

Can authors appeal decisions?

Yes. Appeals are reviewed with clear scientific justification.

Submit Your Manuscript

Publish with rigorous editorial standards and open access visibility.

Submit via ManuscriptZone Simple Manuscript Submission

Need help? Contact us at [email protected]